Seattle, Washington, United States In 2013 was created Juno Therapeutics, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Seattle. The venture was found in North America in United States.
The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top amount of exits for fund were in 2016. The top activity for fund was in 2018.
The fund has no exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight JW Therapeutics, Editas Medicine. Among the most successful fund investment fields, there are Therapeutics, Genetics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Juno Therapeutics, startups are often financed by Third Rock Ventures, Polaris Partners, Partners Innovation Fund. The meaningful sponsors for the fund in investment in the same round are YuanMing Capital, WuXi AppTec, Temasek Holdings. In the next rounds fund is usually obtained by Viking Global Investors, Third Rock Ventures, T. Rowe Price.
The current fund was established by Isabelle Riviu00e8re, Michael Jensen, Michel Sadelain, Phil Greenberg, Renier Brentjens, Stan Riddell.
Related Funds
| Fund Name | Location |
| CFO Rick, Inc. | California, San Francisco, United States |
| Cienega Capital | - |
| Digital Hearts | California, Torrance, United States |
| Greenwich Associates | Connecticut, Stamford, United States |
| Huaze Fangyuan Chuang Tou | Beijing, Beijing, China |
| Launch Fund | California, San Francisco, United States |
| MEGVII | Beijing, Beijing, China |
| New Mexico Small Business Assistance Program | - |
| Osaka Gas | Japan, Osaka, Osaka Prefecture |
| Robotunion | - |
| SalubrisBio | China, Guangdong, Shenzhen |
| Schneider Electric Ventures | California, Menlo Park, United States |
| The Luxembourg Company Deverel | - |
| VC4A | Amsterdam, Noord-Holland, The Netherlands |
| Venturi Group | Minnesota, Saint Paul, United States |
| Versalis | Italy, Lombardia, Lombardy |
| Zell Lurie Commercialization Fund | Ann Arbor, Michigan, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
JW Therapeutics | $100M | 11 Jun 2020 | Shanghai, China | ||
JW Therapeutics | $90M | 07 Mar 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
JW Therapeutics | $100M | 11 Jun 2020 | Shanghai, China | ||
JW Therapeutics | $90M | 07 Mar 2018 | Shanghai, China |
